Abstract:Background: Phloretin (Phl) is a flavonoid compound that contains multiple phenolic hydroxyl groups. It is found in many plants, such as apple leaves, lychee pericarp, and begonia, and has various biological activities, such as antioxidant and anticancer effects. The strong hydrogen bonding between Phl molecules results in poor water solubility and low bioavailability, and thus the scope of the clinical application of Phl is limited. Therefore, it is particularly important to improve the water solubility of Phl for its use to further combat or alleviate skin aging and oxidative damage and develop antioxidant products for the skin. The purpose of this study was to develop and evaluate a phloretin transfersome gel (PTG) preparation for transdermal drug delivery to improve the bioavailability of the drug and delay aging. Methods: Phloretin transfersomes (Phl-TFs) were prepared and optimized by the thin-film dispersion–ultrasonication method. Phl-TFs were characterized by transmission electron microscopy (TEM), differential scanning calorimetry (DSC), Fourier transform infrared (FTIR) spectroscopy, and X-ray diffraction (XRD). The Log P method was used to determine the solubility of the Phl-TFs. The skin penetration ability of the prepared PTG was evaluated using the Franz diffusion cell method. In addition, the in vivo pharmacokinetics of PTG were studied in rats, and an antioxidant activity investigation was conducted using a D-gal rat model. Results: Phl-TFs were successfully prepared with a Soybean Phosphatidylcholine (SPC)/CHOL ratio of 2.7:1 w/v, a phloretin concentration of 1.3 mg/mL, a hydration time of 46 min, an ultrasound time of 5 min, and an ultrasound power of 180 W. The Log P was 2.26, which was significantly higher than that of phloretin (p < 0.05, paired t test). The results of the in vitro penetration test demonstrated that the cumulative skin penetration of the Phl-TFs after 24 h was 842.73 ± 20.86 μg/cm2. The data from an in vivo pharmacokinetic study showed that the Cmax and AUC of PTG were 1.39- and 1.97-fold higher than those of the phloretin solution gel (PSG), respectively (p < 0.05, paired t test). The experimental results in aging rats showed that PTG had a better antioxidant effect. Conclusions: Phl-TFs and PTG preparations with a good shape, safety, and stability were successfully prepared. In vivo pharmacokinetics and preliminary antioxidant experiments further verified the transdermal penetration and antioxidant activity of the phloretin transdermal drug delivery preparation, providing an experimental basis for its further development.

Pharmaceutical Properties of the Phloretin-4,4'-Bipyridine Cocrystal: Structure Analysis, Drug Release Profile, and Antioxidant Activity Research

Facile Tuning of the Photoluminescence and Dissolution Properties of Phloretin Through Cocrystallization

Cocrystal of phloretin with isoniazid: preparation, characterization, and evaluation

Characterization and Antioxidant Activity of the Complex of Phloridzin and Hydroxypropyl-β- Cyclodextrin

Bioaccessibility and Intracellular Antioxidant Activity of Phloretin Embodied by Gliadin/sodium Carboxymethyl Cellulose Nanoparticles

Improving physicochemical properties of Ibrutinib with cocrystal strategy based on structures and natures of the carboxylic acid co-formers

Phloretin Transfersomes for Transdermal Delivery: Design, Optimization, and In Vivo Evaluation

Cocrystals Of Propylthiouracil And Nutraceuticals Toward Sustained-Release: Design, Structure Analysis, And Solid-State Characterization

Cocrystal of curcumin with 4,4′-bipyridine toward improved dissolution: Design, structure analysis, and solid-state characterization

A pharmaceutical cocrystal of apigenin with piperazine: preparation, structural characterization, and dissolution performance

Studies on pharmacokinetic properties and absorption mechanism of phloretin: In vivo and in vitro

Preparation, characterization and evaluation of fenofibrate: benzoic acid cocrystals with enhanced pharmaceutical properties

A novel drug-drug cocrystal of tegafur and myricetin: optimized properties of dissolution and tabletability

Crystal Structure, Solubility, and Pharmacokinetic Study on a Hesperetin Cocrystal with Piperine as Coformer

Cocrystal of Apigenin with Higher Solubility, Enhanced Oral Bioavailability, and Anti-inflammatory Effect

Phenazopyridine-phthalimide Nano-Cocrystal: Release Rate and Oral Bioavailability Enhancement.

A Drug–Drug Cocrystal of Dihydromyricetin and Pentoxifylline

Theoretical Exploration on the Molecular Configurations, Solubilities and Chemical Reactivities of Four Flavonoid-Based Co-Crystals

Formulation, characterization, pharmacokinetics and antioxidant activity of phloretin oral granules

The role of hydroxyl group of ethanol in the self-assembly of pharmaceutical cocrystal of myricetin with 4,4′-bipyridine

Preparation of quercetin-nicotinamide cocrystals and their evaluation underin vivoandin vitroconditions